Wolverine Trading’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26.4M | Buy |
272,300
+19,400
| +8% | +$2.01M | 0.02% | 497 |
|
|
2025
Q2 | $26.9M | Sell |
252,900
-17,700
| -7% | -$1.79M | 0.03% | 377 |
|
|
2025
Q1 | $26.9M | Buy |
270,600
+50,800
| +23% | +$5.12M | 0.03% | 327 |
|
|
2024
Q4 | $19.7M | Buy |
219,800
+17,700
| +9% | +$1.56M | 0.02% | 467 |
|
|
2024
Q3 | $16.8M | Buy |
202,100
+12,200
| +6% | +$962K | 0.02% | 497 |
|
|
2024
Q2 | $14.6M | Buy |
189,900
+107,200
| +130% | +$7.85M | 0.02% | 490 |
|
|
2024
Q1 | $5.66M | Buy |
82,700
+4,500
| +6% | +$289K | 0.01% | 940 |
|
|
2023
Q4 | $4.52M | Sell |
78,200
-7,800
| -9% | -$416K | ﹤0.01% | 1170 |
|
|
2023
Q3 | $4.54M | Buy |
86,000
+20,500
| +31% | +$1.08M | ﹤0.01% | 1074 |
|
|
2023
Q2 | $3.49M | Sell |
65,500
-19,900
| -23% | -$1.04M | ﹤0.01% | 1126 |
|
|
2023
Q1 | $4.24M | Sell |
85,400
-39,500
| -32% | -$1.86M | 0.01% | 930 |
|
|
2022
Q4 | $5.78M | Sell |
124,900
-31,500
| -20% | -$1.36M | 0.01% | 827 |
|
|
2022
Q3 | $6.15M | Sell |
156,400
-53,000
| -25% | -$2.13M | 0.01% | 752 |
|
|
2022
Q2 | $7.92M | Buy |
209,400
+81,800
| +64% | +$3.33M | 0.01% | 609 |
|
|
2022
Q1 | $5.7M | Sell |
127,600
-24,900
| -16% | -$1.08M | 0.01% | 996 |
|
|
2021
Q4 | $6.56M | Sell |
152,500
-28,600
| -16% | -$1.2M | 0.01% | 968 |
|
|
2021
Q3 | $7.95M | Buy |
181,100
+27,300
| +18% | +$1.21M | 0.01% | 965 |
|
|
2021
Q2 | $6.65M | Buy |
153,800
+53,300
| +53% | +$2.24M | 0.01% | 921 |
|
|
2021
Q1 | $3.92M | Sell |
100,500
-89,500
| -47% | -$3.39M | 0.01% | 1321 |
|
|
2020
Q4 | $6.75M | Buy |
+190,000
| New | +$6.85M | 0.01% | 896 |
|
|
2020
Q3 | – | Sell |
-82,000
| Closed | -$2.84M | – | 4522 |
|
|
2020
Q2 | $2.84M | Sell |
82,000
-26,600
| -24% | -$958K | 0.01% | 1157 |
|
|
2020
Q1 | $3.44M | Sell |
108,600
-28,700
| -21% | -$1.12M | 0.01% | 966 |
|
|
2019
Q4 | $6.18M | Sell |
137,300
-8,100
| -6% | -$339K | 0.02% | 949 |
|
|
2019
Q3 | $5.86M | Buy |
+145,400
| New | +$6.16M | 0.02% | 782 |
|
|
2019
Q2 | – | Sell |
-162,800
| Closed | -$6.25M | – | 4430 |
|
|
2019
Q1 | $6.25M | Sell |
162,800
-500
| -0.3% | -$19.1K | 0.02% | 748 |
|
|
2018
Q4 | $5.66M | Sell |
163,300
-159,500
| -49% | -$5.78M | 0.02% | 733 |
|
|
2018
Q3 | $12.4M | Buy |
322,800
+186,800
| +137% | +$6.52M | 0.03% | 464 |
|
|
2018
Q2 | $3.72M | Hold |
136,000
| – | – | 0.01% | 1106 |
|
|
2018
Q1 | $3.72M | Buy |
136,000
+19,400
| +17% | +$527K | 0.01% | 1106 |
|
|
2017
Q4 | $2.89M | Buy |
116,600
+33,200
| +40% | +$916K | 0.01% | 1250 |
|
|
2017
Q3 | $2.43M | Sell |
83,400
-46,100
| -36% | -$1.27M | 0.01% | 1209 |
|
|
2017
Q2 | $3.6M | Buy |
+129,500
| New | +$3.44M | 0.02% | 864 |
|
|
2017
Q1 | – | Sell |
-76,800
| Closed | -$1.66M | – | 4290 |
|
|
2016
Q4 | $1.66M | Sell |
76,800
-24,900
| -24% | -$543K | 0.01% | 1480 |
|
|
2016
Q3 | $2.37M | Sell |
101,700
-51,900
| -34% | -$1.24M | 0.01% | 1212 |
|
|
2016
Q2 | $3.54M | Buy |
+153,600
| New | +$3.32M | 0.02% | 768 |
|
Other funds holding BSX
Wolverine Trading's BSX Position: Q3 2025 in Review
Wolverine Trading increased its Boston Scientific (BSX) stake by 205% in Q3 2025, buying an estimated $777K and bringing the position to 11,165 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2816.
Wolverine Trading first reported a position in BSX in Q2 2016 and has held it in 29 quarters since. The position peaked at $5.37M in Q4 2019. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.
- Wolverine Trading held 11,165 shares of Boston Scientific worth $1.08M as of Q3 2025.
- Wolverine Trading bought 7,499 Boston Scientific shares in Q3 2025, an estimated $777K.
- Boston Scientific made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2816 holding.
- Wolverine Trading first reported a position in Boston Scientific in Q2 2016 and has held it in 29 quarters since.
- Wolverine Trading's Boston Scientific position peaked at $5.37M in Q4 2019.
- 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.